Literature DB >> 21742285

Anthroposophic health care in Sweden - a patient evaluation.

Maria Arman1, Anne-Sofie Hammarqvist, Anna Kullberg.   

Abstract

This study surveyed patients and their satisfaction with an integrative anthroposophic hospital. The patients were followed up by questionnaires up to six months after a stay in a Swedish clinic. Satisfaction with the care, life satisfaction, and health-related quality of life were measured for 53 patients, 48 women, 5 men, with cancer, pain diseases, and psychosomatic problems. Sampling was consecutive and due to regional reasons. The evaluation of patients' satisfaction from the anthroposophic clinic (AC) was compared to similar questions of patients using conventional hospital care. The stay lasted 7-21 days and was paid by the patients' county councils. Causes for choosing AC were predominantly a positive attitude towards a holistic health view and expectations on being cared for. Less frequently noted was dissatisfaction with conventional care. Satisfaction with health care given after one month by the AC was sample scored more positively than the highest unit in the conventional clinic. This is important because women in conventional clinic report lower satisfaction. The AC sample consisted of 91% women with an average age of 54 years and a higher level of education compared to the sample from the conventional hospital. Health-related quality of life and life satisfaction was, if not significant, moderately increased during the following six months. The AC initiated a new attitude and change in life habits that stimulated the patients into improving their life style habits and hence their overall health. Still challenging is the gender question. Why do middle-aged, well-educated women experience a need for and a satisfaction in complementary and integrative health care?
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21742285     DOI: 10.1016/j.ctcp.2010.11.001

Source DB:  PubMed          Journal:  Complement Ther Clin Pract        ISSN: 1744-3881            Impact factor:   2.446


  7 in total

1.  Patient-centered outcomes on quality of life and anthroposophic healthcare: a qualitative triangulation study.

Authors:  Evi B Koster; Erik W Baars; Diana M J Delnoij
Journal:  Qual Life Res       Date:  2016-03-28       Impact factor: 4.147

2.  Intravenous Mistletoe Treatment in Integrative Cancer Care: A Qualitative Study Exploring the Procedures, Concepts, and Observations of Expert Doctors.

Authors:  Gunver S Kienle; Milena Mussler; Dieter Fuchs; Helmut Kiene
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-24       Impact factor: 2.629

3.  Usage and cost of first-line drugs for patients referred to inpatient anthroposophic integrative care or inpatient conventional care for stress-related mental disorders--a register based study.

Authors:  Tobias Sundberg; Laith Hussain-Alkhateeb; Torkel Falkenberg
Journal:  BMC Complement Altern Med       Date:  2015-10-14       Impact factor: 3.659

4.  Ecological caring-Revisiting the original ideas of caring science.

Authors:  Helena Dahlberg; Albertine Ranheim; Karin Dahlberg
Journal:  Int J Qual Stud Health Well-being       Date:  2016-11-30

5.  Individualized Integrative Cancer Care in Anthroposophic Medicine: A Qualitative Study of the Concepts and Procedures of Expert Doctors.

Authors:  Gunver S Kienle; Milena Mussler; Dieter Fuchs; Helmut Kiene
Journal:  Integr Cancer Ther       Date:  2016-05-04       Impact factor: 3.279

6.  Long-term outcomes of anthroposophic treatment for chronic disease: a four-year follow-up analysis of 1510 patients from a prospective observational study in routine outpatient settings.

Authors:  Harald Johan Hamre; Helmut Kiene; Anja Glockmann; Renatus Ziegler; Gunver Sophia Kienle
Journal:  BMC Res Notes       Date:  2013-07-13

7.  Opposite drug prescription and cost trajectories following integrative and conventional care for pain--a case-control study.

Authors:  Tobias Sundberg; Max Petzold; Niko Kohls; Torkel Falkenberg
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.